EUZ Eckert & Ziegler Strahlen-und Medizinte AG

XETRA · DE · Healthcare · Medical Devices · ezag.com

12.35EUR+0.16%Mkt Cap: 840.02M $P/E: 15.443d ago

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small imp…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap840.02M USD

Enterprise Value766.17M USD

Revenue (TTM)339.67M USD

Gross Profit166.28M USD

Net Income (TTM)53.00M USD

Revenue/Share4.99 EUR

Last Price12.35 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.1K

CountryDE

SectorHealthcare

IndustryMedical Devices

ISINDE0005659700

Valuation

P/E (Trailing)15.44

P/E (Forward)14.32

PEG0.91

EV/EBITDA7.95

EV/Revenue2.26

P/S2.47

P/B2.87

EPS (TTM)0.79

EPS (Forward)0.86

52W Range

12.015% of range18.26

52W High18.26 EUR

52W Low12.01 EUR

Profitability

Gross Margin49.04%

Oper. Margin22.71%

EBITDA Margin28.37%

Profit Margin15.63%

ROE19.37%

ROA10.65%

Growth

Revenue Growth-5.20%

Earnings Growth1.50%

Cash Flow & Leverage

Operating CF63.48M USD

CapEx (TTM)28.28M USD

FCF Margin3.99%

FCF Yield1.61%

Net Debt-75.31M USD

Net Debt/EBITDA-0.78

Balance Sheet

Debt/Equity0.18

Current Ratio3.48

Quick Ratio2.65

Book Value/Sh4.30 EUR

Cash/Share1.76 EUR

Dividends

Fwd Div Rate0.22 EUR

Trail. Div Rate0.22 EUR

Div. Yield1.78%

5Y Avg Yield0.37%

Payout Ratio27.85%

Ex-Div DateJun 25, 2026

Pay Date—

Splits

Last Split3:1

Split DateAug 13, 2025

Analyst Consensus

Rating—

Target (Mean)21.60 EUR

Upside (mean)+74.9%

Target Range20.30 EUR – 23.00 EUR

20.30+74.9% to mean23.00

# Analysts3

Ownership

Shares Out.62.58M

Float42.79M

Insiders31.16%

Institutions24.95%

Technical

SMA 5013.01 (-5.0%)

SMA 20014.60 (-15.4%)

Beta1.47

S&P 52W Chg14.58%

Avg Vol (30d)109.54K

Avg Vol (10d)90.59K

Technical Indicators

RSI (14)44.3

MACD-0.1795

MACD Signal-0.2477

MACD Hist.+0.0683

BB Upper12.71 EUR

BB Middle12.36 EUR

BB Lower12.00 EUR

BB Width5.71%

ATR (14)0.3181 EUR

Vol Ratio (20d)0.98x